Connection

Yuko Palesch to Aged

Back to Details
This is a "connection" page, showing publications Yuko Palesch has written about Aged.
Yuko Palesch
Connection Strength
0.731
Aged
  1. Twelve-Month Clinical and Quality-of-Life Outcomes in the Interventional Management of Stroke III Trial. Stroke. 2015 May; 46(5):1321-7.
    View in: PubMed
    Score: 0.041
  2. Platelet-oriented inhibition in new TIA and minor ischemic stroke (POINT) trial: rationale and design. Int J Stroke. 2013 Aug; 8(6):479-83.
    View in: PubMed
    Score: 0.037
  3. Minimal sufficient balance-a new strategy to balance baseline covariates and preserve randomness of treatment allocation. Stat Methods Med Res. 2015 Dec; 24(6):989-1002.
    View in: PubMed
    Score: 0.033
  4. Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) II: design, methods, and rationale. Neurocrit Care. 2011 Dec; 15(3):559-76.
    View in: PubMed
    Score: 0.033
  5. The ALIAS Pilot Trial: a dose-escalation and safety study of albumin therapy for acute ischemic stroke--II: neurologic outcome and efficacy analysis. Stroke. 2006 Aug; 37(8):2107-14.
    View in: PubMed
    Score: 0.023
  6. Intensive blood pressure lowering with nicardipine and outcomes after intracerebral hemorrhage: An individual participant data systematic review. Int J Stroke. 2022 06; 17(5):494-505.
    View in: PubMed
    Score: 0.016
  7. Regional Differences in the Response to Acute Blood Pressure Lowering After Cerebral Hemorrhage. Neurology. 2021 02 02; 96(5):e740-e751.
    View in: PubMed
    Score: 0.015
  8. Sex Differences in Blood Pressure-Lowering Therapy and Outcomes Following Intracerebral Hemorrhage: Results From ATACH-2. Stroke. 2020 08; 51(8):2282-2286.
    View in: PubMed
    Score: 0.015
  9. Late Neurological Deterioration after Acute Intracerebral Hemorrhage: A post hoc Analysis of the ATACH-2 Trial. Cerebrovasc Dis. 2020; 49(1):26-31.
    View in: PubMed
    Score: 0.014
  10. National Institutes of Health Stroke Scale: An Alternative Primary Outcome Measure for Trials of Acute Treatment for Ischemic Stroke. Stroke. 2020 01; 51(1):282-290.
    View in: PubMed
    Score: 0.014
  11. Assessment of the End Point Adjudication Process on the Results of the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial: A Secondary Analysis. JAMA Netw Open. 2019 09 04; 2(9):e1910769.
    View in: PubMed
    Score: 0.014
  12. Blood pressure control and clinical outcomes in acute intracerebral haemorrhage: a preplanned pooled analysis of individual participant data. Lancet Neurol. 2019 09; 18(9):857-864.
    View in: PubMed
    Score: 0.014
  13. Risk for Major Hemorrhages in Patients Receiving Clopidogrel and Aspirin Compared With Aspirin Alone After Transient Ischemic Attack or Minor Ischemic Stroke: A Secondary Analysis of the POINT Randomized Clinical Trial. JAMA Neurol. 2019 07 01; 76(7):774-782.
    View in: PubMed
    Score: 0.014
  14. Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial. Lancet Neurol. 2019 05; 18(5):428-438.
    View in: PubMed
    Score: 0.014
  15. Clinical Outcomes Depending on Acute Blood Pressure After Cerebral Hemorrhage. Ann Neurol. 2019 01; 85(1):105-113.
    View in: PubMed
    Score: 0.013
  16. The AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenic stroke randomized trial: Rationale and methods. Int J Stroke. 2019 02; 14(2):207-214.
    View in: PubMed
    Score: 0.013
  17. Blood Pressure-Attained Analysis of ATACH 2 Trial. Stroke. 2018 06; 49(6):1412-1418.
    View in: PubMed
    Score: 0.013
  18. Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA. N Engl J Med. 2018 Jul 19; 379(3):215-225.
    View in: PubMed
    Score: 0.013
  19. Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging. N Engl J Med. 2018 02 22; 378(8):708-718.
    View in: PubMed
    Score: 0.013
  20. Prehospital Intubation is Associated with Favorable Outcomes and Lower Mortality in ProTECT III. Prehosp Emerg Care. 2017 Sep-Oct; 21(5):539-544.
    View in: PubMed
    Score: 0.012
  21. A multicenter randomized controlled trial of endovascular therapy following imaging evaluation for ischemic stroke (DEFUSE 3). Int J Stroke. 2017 10; 12(8):896-905.
    View in: PubMed
    Score: 0.012
  22. Endovascular Therapy of M2 Occlusion in IMS III: Role of M2 Segment Definition and Location on Clinical and Revascularization Outcomes. AJNR Am J Neuroradiol. 2017 Jan; 38(1):84-89.
    View in: PubMed
    Score: 0.012
  23. Intensive Blood-Pressure Lowering in Patients with Acute Cerebral Hemorrhage. N Engl J Med. 2016 09 15; 375(11):1033-43.
    View in: PubMed
    Score: 0.011
  24. Very Early Administration of Progesterone Does Not Improve Neuropsychological Outcomes in Subjects with Moderate to Severe Traumatic Brain Injury. J Neurotrauma. 2017 01 01; 34(1):115-120.
    View in: PubMed
    Score: 0.011
  25. Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic Stroke: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2016 Feb; 47(2):581-641.
    View in: PubMed
    Score: 0.011
  26. Endovascular Therapy Is Effective and Safe for Patients With Severe Ischemic Stroke: Pooled Analysis of Interventional Management of Stroke III and Multicenter Randomized Clinical Trial of Endovascular Therapy for Acute Ischemic Stroke in the Netherlands Data. Stroke. 2015 Dec; 46(12):3416-22.
    View in: PubMed
    Score: 0.011
  27. Albumin Administration in Acute Ischemic Stroke: Safety Analysis of the ALIAS Part 2 Multicenter Trial. PLoS One. 2015; 10(9):e0131390.
    View in: PubMed
    Score: 0.011
  28. Outcome Differences between Intra-Arterial Iso- and Low-Osmolality Iodinated Radiographic Contrast Media in the Interventional Management of Stroke III Trial. AJNR Am J Neuroradiol. 2015 Nov; 36(11):2074-81.
    View in: PubMed
    Score: 0.011
  29. Recombinant tissue-type plasminogen activator plus eptifibatide versus recombinant tissue-type plasminogen activator alone in acute ischemic stroke: propensity score-matched post hoc analysis. Stroke. 2015 Feb; 46(2):461-4.
    View in: PubMed
    Score: 0.010
  30. Very early administration of progesterone for acute traumatic brain injury. N Engl J Med. 2014 Dec 25; 371(26):2457-66.
    View in: PubMed
    Score: 0.010
  31. Endovascular revascularization results in IMS III: intracranial ICA and M1 occlusions. J Neurointerv Surg. 2015 Nov; 7(11):795-802.
    View in: PubMed
    Score: 0.010
  32. Evolution of practice during the Interventional Management of Stroke III Trial and implications for ongoing trials. Stroke. 2014 Dec; 45(12):3606-11.
    View in: PubMed
    Score: 0.010
  33. Recanalization and clinical outcome of occlusion sites at baseline CT angiography in the Interventional Management of Stroke III trial. Radiology. 2014 Oct; 273(1):202-10.
    View in: PubMed
    Score: 0.010
  34. Increased brain volume among good grade patients with intracerebral hemorrhage. Results from the Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) study. Neurocrit Care. 2014 Jun; 20(3):470-5.
    View in: PubMed
    Score: 0.010
  35. Drivers of costs associated with reperfusion therapy in acute stroke: the Interventional Management of Stroke III Trial. Stroke. 2014 Jun; 45(6):1791-8.
    View in: PubMed
    Score: 0.010
  36. Time to angiographic reperfusion and clinical outcome after acute ischaemic stroke: an analysis of data from the Interventional Management of Stroke (IMS III) phase 3 trial. Lancet Neurol. 2014 Jun; 13(6):567-74.
    View in: PubMed
    Score: 0.010
  37. Collaterals at angiography and outcomes in the Interventional Management of Stroke (IMS) III trial. Stroke. 2014 Mar; 45(3):759-64.
    View in: PubMed
    Score: 0.010
  38. Alberta Stroke Program early computed tomography score to select patients for endovascular treatment: Interventional Management of Stroke (IMS)-III Trial. Stroke. 2014 Feb; 45(2):444-9.
    View in: PubMed
    Score: 0.009
  39. High dose deferoxamine in intracerebral hemorrhage (HI-DEF) trial: rationale, design, and methods. Neurocrit Care. 2013 Oct; 19(2):257-66.
    View in: PubMed
    Score: 0.009
  40. High-dose albumin treatment for acute ischaemic stroke (ALIAS) Part 2: a randomised, double-blind, phase 3, placebo-controlled trial. Lancet Neurol. 2013 Nov; 12(11):1049-58.
    View in: PubMed
    Score: 0.009
  41. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med. 2013 Mar 07; 368(10):893-903.
    View in: PubMed
    Score: 0.009
  42. Reliability of hematoma volume measurement at local sites in a multicenter acute intracerebral hemorrhage clinical trial. Stroke. 2013 Jan; 44(1):237-9.
    View in: PubMed
    Score: 0.009
  43. Systolic blood pressure reduction and risk of acute renal injury in patients with intracerebral hemorrhage. Am J Med. 2012 Jul; 125(7):718.e1-6.
    View in: PubMed
    Score: 0.008
  44. Association of serum glucose concentrations during acute hospitalization with hematoma expansion, perihematomal edema, and three month outcome among patients with intracerebral hemorrhage. Neurocrit Care. 2011 Dec; 15(3):428-35.
    View in: PubMed
    Score: 0.008
  45. Safety and tolerability of deferoxamine mesylate in patients with acute intracerebral hemorrhage. Stroke. 2011 Nov; 42(11):3067-74.
    View in: PubMed
    Score: 0.008
  46. The Albumin in Acute Stroke Part 1 Trial: an exploratory efficacy analysis. Stroke. 2011 Jun; 42(6):1621-5.
    View in: PubMed
    Score: 0.008
  47. The albumin in acute stroke (ALIAS) multicenter clinical trial: safety analysis of part 1 and rationale and design of part 2. Stroke. 2011 Jan; 42(1):119-27.
    View in: PubMed
    Score: 0.008
  48. Strokes with minor symptoms: an exploratory analysis of the National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator trials. Stroke. 2010 Nov; 41(11):2581-6.
    View in: PubMed
    Score: 0.008
  49. Effect of systolic blood pressure reduction on hematoma expansion, perihematomal edema, and 3-month outcome among patients with intracerebral hemorrhage: results from the antihypertensive treatment of acute cerebral hemorrhage study. Arch Neurol. 2010 May; 67(5):570-6.
    View in: PubMed
    Score: 0.007
  50. Effect of combined aspirin and extended-release dipyridamole versus clopidogrel on functional outcome and recurrence in acute, mild ischemic stroke: PRoFESS subgroup analysis. Stroke. 2010 Apr; 41(4):732-8.
    View in: PubMed
    Score: 0.007
  51. Effect of telmisartan on functional outcome, recurrence, and blood pressure in patients with acute mild ischemic stroke: a PRoFESS subgroup analysis. Stroke. 2009 Nov; 40(11):3541-6.
    View in: PubMed
    Score: 0.007
  52. Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study. Lancet Neurol. 2008 Oct; 7(10):875-84.
    View in: PubMed
    Score: 0.007
  53. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke. N Engl J Med. 2008 Sep 18; 359(12):1238-51.
    View in: PubMed
    Score: 0.007
  54. Telmisartan to prevent recurrent stroke and cardiovascular events. N Engl J Med. 2008 Sep 18; 359(12):1225-37.
    View in: PubMed
    Score: 0.007
  55. Methodology of the Interventional Management of Stroke III Trial. Int J Stroke. 2008 May; 3(2):130-7.
    View in: PubMed
    Score: 0.006
  56. Using the baseline CT scan to select acute stroke patients for IV-IA therapy. AJNR Am J Neuroradiol. 2006 Sep; 27(8):1612-6.
    View in: PubMed
    Score: 0.006
  57. The ALIAS Pilot Trial: a dose-escalation and safety study of albumin therapy for acute ischemic stroke--I: Physiological responses and safety results. Stroke. 2006 Aug; 37(8):2100-6.
    View in: PubMed
    Score: 0.006
  58. Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes correlates with traditional predictors of prognosis: an interim analysis of a prospective multi-institutional cohort study. Ann Surg. 2004 Jun; 239(6):828-37; discussion 837-40.
    View in: PubMed
    Score: 0.005
  59. The nursing home population: different perspectives and implications for policy. Health Care Financ Rev. 1981 Dec; 3(2):15-23.
    View in: PubMed
    Score: 0.004
  60. Age and alarm symptoms do not predict endoscopic findings among patients with dyspepsia: a multicentre database study. Gut. 2001 Jul; 49(1):29-34.
    View in: PubMed
    Score: 0.004
  61. Alcohol and mortality: the Honolulu Heart Study. Am J Med. 1980 Feb; 68(2):164-9.
    View in: PubMed
    Score: 0.004
  62. Polymorphic cytokine genotypes as markers of disease severity in adult periodontitis. J Clin Periodontol. 1999 Nov; 26(11):705-9.
    View in: PubMed
    Score: 0.004
  63. The body mass index-mortality relationship in white and African American women. Obes Res. 1998 Jul; 6(4):268-77.
    View in: PubMed
    Score: 0.003
  64. The effect of bupivacaine skull block on the hemodynamic response to craniotomy. Anesth Analg. 1996 Dec; 83(6):1256-61.
    View in: PubMed
    Score: 0.003
  65. Sex differences in declining cohort death rates from heart disease. Am J Public Health. 1982 Feb; 72(2):161-6.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.